InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Schiller Mark C.. Director active across 1 company, notably Kezar Life Sciences, Inc.. Cumulatively, 2 filings have been published. Split: 0 buy · 2 sells. Total volume traded: €6k. Activity tracked since 2 July 2024. The latest transaction was disclosed on 2 July 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations